The store will not work correctly when cookies are disabled.
4-(3-chloropropyl)-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-1,2,3-triazole
ID: ALA235578
PubChem CID: 44434483
Max Phase: Preclinical
Molecular Formula: C12H9Cl3F3N3
Molecular Weight: 358.58
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: FC(F)(F)c1cc(Cl)c(-n2cc(CCCCl)nn2)c(Cl)c1
Standard InChI: InChI=1S/C12H9Cl3F3N3/c13-3-1-2-8-6-21(20-19-8)11-9(14)4-7(5-10(11)15)12(16,17)18/h4-6H,1-3H2
Standard InChI Key: CVZWKJSPJYNXCC-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
7.5432 -5.3273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3282 -5.0736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3315 -4.2485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5450 -3.9912 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0618 -4.6588 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2368 -4.6578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8287 -3.9430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0044 -3.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5903 -4.6562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0063 -5.3735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8292 -5.3713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7653 -4.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9333 -4.6930 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.7470 -3.8315 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.7917 -5.4809 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.2443 -6.0843 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.2435 -3.2298 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.9943 -5.5604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9058 -6.3807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5718 -6.8675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4833 -7.6877 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
10 11 2 0
11 6 1 0
1 2 2 0
9 12 1 0
5 6 1 0
12 13 1 0
12 14 1 0
6 7 2 0
12 15 1 0
2 3 1 0
11 16 1 0
7 8 1 0
7 17 1 0
3 4 2 0
2 18 1 0
8 9 2 0
18 19 1 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 358.58 | Molecular Weight (Monoisotopic): 356.9814 | AlogP: 4.76 | #Rotatable Bonds: 4 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.22 | CX LogP: 4.96 | CX LogD: 4.96 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.74 | Np Likeness Score: -1.55 |
References
1. Alam MS, Huang J, Ozoe F, Matsumura F, Ozoe Y.. (2007) Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors., 15 (15): [PMID:17544280] [10.1016/j.bmc.2007.05.039] |